Skip to content

CDR

PhRMA: What’s ahead for biopharmaceuticals in 2013?

It’s human nature to look ahead to the New Year. What will 2013 hold for America’s biopharmaceutical research sector? Well, quite a bit. John Castellani We will join other stakeholders in the dialogue over the role of health care costs in our nation’s economic challenges.

Wasson, Pessina are <i>CDR’s</i> Retailers of the Year

Wasson, Pessina are <i>CDR’s</i> Retailers of the Year

Striking a blockbuster deal that could shift the industry’s perspective, Walgreen Co. chief executive officer Greg Wasson and Alliance Boots executive chairman Stefano Pessina — and their management teams — have been selected as the 2012 Retailers of the Year by Chain Drug Review.

Watson cleared to release Lysteda generic

Watson Pharmaceuticals Inc. has received approval from the Food and Drug Administration for tranexamic acid tablets, a medication for menstrual bleeding. The company said Thursday that it will immediately begin shipping the product, which is a generic equivalent to Ferring Pharmaceuticals’ Lysteda.

December comp-store sales decrease at Walgreens

December comp-store sales decrease at Walgreens

Comparable-store sales at Walgreen Co. remained on the downside in December, as calendar day shifts and introductions of lower-price generic drugs impacted results. Walgreens said Friday that December same-store sales fell 6.1% from a year earlier. Calendar day shifts accounted for 1.

Unilever to divest Skippy peanut butter brand

Unilever has agreed to sell its global Skippy peanut butter business to Hormel Foods for about $700 million. The deal, announced Thursday, includes Unilever’s Skippy manufacturing facilities in Little Rock, Ark., and Weifang, China.

AmerisourceBergen adds board member

AmerisourceBergen Corp. has elected former Campbell Soup Co. chief executive officer Douglas Conant to its board of directors. The pharmaceutical distributor said Wednesday that the addition of Conant increases the number of board directors from nine to 10.

Sales at Rite Aid decline in December

Sales at Rite Aid decline in December

Despite solid script count growth, Rite Aid Corp. reported declined same-store sales for December. Rite Aid said Thursday that for the four weeks ended Dec. 29, comparable-store sales were down 2.2% year over year.

Rite Aid plans free health screenings

In line with its focus on wellness empowerment, Rite Aid Corp. is providing customers with a free health guide, online health resources and expert advice from its pharmacists to help support their efforts to improve their well-being as they look to the new year.